Exosome Research: Current Science and Regulatory Landscape

Disclaimer

Clinical Application Notice

Important information before proceeding

• Clinical Protocols: This course discusses research-based protocols and clinical considerations. These are for educational purposes only and do not constitute treatment recommendations. Many therapies discussed are investigational.
• Professional Responsibility: You bear ultimate responsibility for clinical decisions. Always exercise independent professional judgment for each patient.
• Regulatory Compliance: You must verify compliance with FDA regulations, state medical board requirements, and local laws in your jurisdiction. Exosome and stem cell therapies are not FDA-approved for therapeutic use. PRP applications are considered off-label.
• Due Diligence Required: Conduct your own research and verification. Treatment outcomes vary, many therapies are investigational, and these protocols do not guarantee specific results.
• Liability Notice: Longerton University is not responsible for outcomes resulting from the application of course content to patient care.

I am a licensed healthcare professional. I understand these protocols are educational, many therapies discussed are investigational and not FDA-approved, and I am solely responsible for regulatory compliance, due diligence, and patient outcomes in my practice.